Health care of Kyrgyzstan
Zdravoohraneniye Kyrgyzstana

ISSN 1694-8068 (Print)

ISSN 1694-805X (Online)

Log in

Spirometry indicators in patients with chronic obstructive pulmonary disease in low and high altitude conditions

https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
Spirometry indicators in patients with chronic obstructive pulmonary disease in low and high altitude conditions
Полный текст  

PDF (RUS)
Abstract About the authors References

Abstract

Objective. The purpose of the work is to study spirometry indicators in patients with chronic obstructive pulmonary disease (COPD) in high altitude conditions. Material and methods. The work involved 86 residents of high mountains (group 1) suffering from COPD; 100 patients living in low mountains (group 2) suffering from COPD and 86 people in the control group (healthy patients living in standard geographical conditions). During spirometry, the following parameters were studied: vital capacity, forced vital capacity, forced expiratory volume in 1 second, peak expiratory flow. The analysis of the obtained results was carried out using the program “STATISTICA for Windows Version 10.0” (Statsoft, Inc, USA). Results. In patients living in high altitude conditions, vital capacity values are significantly lower than in healthy individuals living in high altitude conditions (65.9 ± 1.8 l and 88.4 ± 2.4 l). When analyzing the FEV1 parameter, it was noted to decrease in patients with COPD living in high and low mountains compared to healthy individuals (52.5 ± 2.3 l; 50.8 ± 2.0 l; 72.4 ± 1, 7 liters, respectively), p<0.05. The PEF rate in highland residents was also lower compared to healthy respondents living in similar geographic conditions (53.6 ± 2.3% and 64.4 ± 2.3%, respectively). Conclusions. 1. The study of spirometry parameters (VC, FVC, FEV1, PEF) in patients with COPD and living in high mountains indicates their significant decrease compared to the results of parameters in healthy individuals living in high mountains (p <0.05; <0.001); 2. In residents of high mountains, the respiratory rate was significantly lower than that of patients with COPD living in low mountains (20.9 ± 0.3 per minute and 22.9 ± 0.3 per minute, p = 0.001).

About the authors

Асанбаева Анара Абдимиталиповна, аспирант кафедры семейной медицины последипломного образования Кыргызской государственной медицинской академии им. И. К. Ахунбаева, Бишкек, Кыргызская Республика

Бримкулов Нурлан Нургазиевич, доктор медицинских наук, профессор, заведующий кафедрой семейной медицины последипломного образования Кыргызской государственной медицинской ака демии им. И. К. Ахунбаева, Бишкек, Кыргызская Республика

Asanbaeva Anara Abdimitalipovna, graduate student of the Department of Family Medicine of Postgraduate Education of the Kyrgyz State Medical Academy named after. I. K. Akhunbaeva, Bishkek, Kyrgyz Republic

Brimkulov Nurlan Nurgazievich, Doctor of Medical Sciences, Professor, Head of the Department of Family Medicine of Postgraduate Education of the Kyrgyz State Medical Academy named after. I. K. Akhun baeva, Bishkek, Kyrgyz Republic

Асанбаева Анара Абдимиталиповна, И.К. Ахунбаев атындагы Кыргыз мамлекеттик медициналык академиясынын дипломдон кийинки билим берүү үй-бүлөлүк медицина кафедрасынын аспиранты, Бишкек, Кыргыз Республикасы

Бримкулов Нурлан Нургазиевич, медицина илимдеринин доктору, профессор, И.К. Ахунбаев атындагы Кыргыз мамлекеттик медициналык академиясынын дипломдон кийинки билим берүү үй-бүлөлүк медицина кафедрасынын башчысы, Бишкек, Кыргыз Республикасы

References

  1. Celli B.R., Singh D., Vogelmeier C., Agusti A. New Perspectives on Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022, no. 17, pp. 2127-2136.
  2. Avdeev S., Aisanov Z., Arkhipov V., et al. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. Int J COPD. 2019, no.14, pp. 1267-80.
  3. АжимаматоваР.М., КалматовР.К. Распространенность и социально-экономический ущерб от болезней органов дыхания в мире, в том числе в Кыргызской Республике // Вестник Ошского государственного университета. -2020. -№ 1-5.- C.18-24. [Azhimamatova R.M., Kalmatov R.K. Prevalence and social-economic damage of respiratory diseases in the worldwide including Kyrgyz Republic. // Bulletin of Osh State University. 2020;1(5) 18-24 (In Russ.)].
  4. Драпкина О.М., Концевая А.В., Муканеева Д.К., Смирнова М.И., Анциферова А.А., Лукьянов М.М., Мырзаматова А.О., Моховиков Г.И., Худяков М.Б., Авдеев С.Н. Прогноз социально-экономического бремени хронической обструктивной болезни легких в Российской Федерации в 2022 году. // Пульмонология. 2022;32(4): С. 507-516. [Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M., Myrzamatova A.O., Mokhovikov G.I., Khudyakov M.B., Avdeev S.N. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022.  2022;32(4):507-516. (In Russ.)].
  5. Tollånes M.C., Sjaastad G.E., Aarli B.B., Sandberg S. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Pract. 2020. Vol.21, no.1, P. 235.
  6. Soumagne T., Guillien A., Roux P., et al. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice. Respiratory Medicine and Research. 2020, no,77. pp. 31-36.
  7. Graham B.L, Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper Bg., et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019, vol.200, no.8, pp.e70-e88.
  8. Vinnikov D,V., Raushanova A, Kyzayeva A, Romanova Z, Tulekov Z.D., et al. Lifetime Occupational history, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int J Chron Obstruct Pulmon Dis. 2019, vol.14, pp.3025-3034.
  9. Athlin Å., Lisspers K., Hasselgren M., et al. Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. Npj Prim. Care Respir. Med. 2023, no 33, P. 23.
  10. Lange A.V., Mehta A.B., BekelmanB. How Important is Spirometry for Identifying Patients with COPD Appropriate for Palliative Care? Journal of Pain and Symptom Management. 2023, vol.65. no.3, pp. e181-e187.

                                                                                               

  1. Celli B.R., Singh D., Vogelmeier C., Agusti A. New Perspectives on Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022, no. 17, pp. 2127-2136.
  2. Avdeev S., Aisanov Z., Arkhipov V., et al. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. Int J COPD. 2019, no.14, pp. 1267-80.
  3. АжимаматоваР.М., КалматовР.К. Распространенность и социально-экономический ущерб от болезней органов дыхания в мире, в том числе в Кыргызской Республике // Вестник Ошского государственного университета. -2020. -№ 1-5.- C.18-24. [Azhimamatova R.M., Kalmatov R.K. Prevalence and social-economic damage of respiratory diseases in the worldwide including Kyrgyz Republic. // Bulletin of Osh State University. 2020;1(5) 18-24 (In Russ.)].
  4. Драпкина О.М., Концевая А.В., Муканеева Д.К., Смирнова М.И., Анциферова А.А., Лукьянов М.М., Мырзаматова А.О., Моховиков Г.И., Худяков М.Б., Авдеев С.Н. Прогноз социально-экономического бремени хронической обструктивной болезни легких в Российской Федерации в 2022 году. // Пульмонология. 2022;32(4): С. 507-516. [Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M., Myrzamatova A.O., Mokhovikov G.I., Khudyakov M.B., Avdeev S.N. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022.  2022;32(4):507-516. (In Russ.)].
  5. Tollånes M.C., Sjaastad G.E., Aarli B.B., Sandberg S. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Pract. 2020. Vol.21, no.1, P. 235.
  6. Soumagne T., Guillien A., Roux P., et al. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice. Respiratory Medicine and Research. 2020, no,77. pp. 31-36.
  7. Graham B.L, Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper Bg., et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019, vol.200, no.8, pp.e70-e88.
  8. Vinnikov D,V., Raushanova A, Kyzayeva A, Romanova Z, Tulekov Z.D., et al. Lifetime Occupational history, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int J Chron Obstruct Pulmon Dis. 2019, vol.14, pp.3025-3034.
  9. Athlin Å., Lisspers K., Hasselgren M., et al. Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. Npj Prim. Care Respir. Med. 2023, no 33, P. 23.
  10. Lange A.V., Mehta A.B., BekelmanB. How Important is Spirometry for Identifying Patients with COPD Appropriate for Palliative Care? Journal of Pain and Symptom Management. 2023, vol.65. no.3, pp. e181-e187.

                                                                                               

  1. Celli B.R., Singh D., Vogelmeier C., Agusti A. New Perspectives on Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022, no. 17, pp. 2127-2136.
  2. Avdeev S., Aisanov Z., Arkhipov V., et al. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. Int J COPD. 2019, no.14, pp. 1267-80.
  3. АжимаматоваР.М., КалматовР.К. Распространенность и социально-экономический ущерб от болезней органов дыхания в мире, в том числе в Кыргызской Республике // Вестник Ошского государственного университета. -2020. -№ 1-5.- C.18-24. [Azhimamatova R.M., Kalmatov R.K. Prevalence and social-economic damage of respiratory diseases in the worldwide including Kyrgyz Republic. // Bulletin of Osh State University. 2020;1(5) 18-24 (In Russ.)].
  4. Драпкина О.М., Концевая А.В., Муканеева Д.К., Смирнова М.И., Анциферова А.А., Лукьянов М.М., Мырзаматова А.О., Моховиков Г.И., Худяков М.Б., Авдеев С.Н. Прогноз социально-экономического бремени хронической обструктивной болезни легких в Российской Федерации в 2022 году. // Пульмонология. 2022;32(4): С. 507-516. [Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M., Myrzamatova A.O., Mokhovikov G.I., Khudyakov M.B., Avdeev S.N. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022.  2022;32(4):507-516. (In Russ.)].
  5. Tollånes M.C., Sjaastad G.E., Aarli B.B., Sandberg S. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Pract. 2020. Vol.21, no.1, P. 235.
  6. Soumagne T., Guillien A., Roux P., et al. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice. Respiratory Medicine and Research. 2020, no,77. pp. 31-36.
  7. Graham B.L, Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper Bg., et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019, vol.200, no.8, pp.e70-e88.
  8. Vinnikov D,V., Raushanova A, Kyzayeva A, Romanova Z, Tulekov Z.D., et al. Lifetime Occupational history, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int J Chron Obstruct Pulmon Dis. 2019, vol.14, pp.3025-3034.
  9. Athlin Å., Lisspers K., Hasselgren M., et al. Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. Npj Prim. Care Respir. Med. 2023, no 33, P. 23.
  10. Lange A.V., Mehta A.B., BekelmanB. How Important is Spirometry for Identifying Patients with COPD Appropriate for Palliative Care? Journal of Pain and Symptom Management. 2023, vol.65. no.3, pp. e181-e187.

                                                                                               

Keywords
high-altitude , Chronic obstructive disease , Spirometry , Vital capacity , Peak expiratory flow
Для цитирования

Асанбаева А.А., Бримкулов Н.Н. Показатели спирометрии у больных ХОБЛ в условиях низко и высокогорья. Здравоохранение Кыргызстана 2023, № 4, с.10-16. https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
For citation

Asanbaeva A.A., Brimkulov N.N. Spirometry indicators in patients with chronic obstructive pulmonary disease in low and high altitude conditions Health care of Kyrgyzstan 2023,  No.4, pp.10-16. https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
Цитата үчүн

Асанбаева А.А., Бримкулов Н.Н. Төмөнкү жана бийик тоолуу шарттарда өпкөнүн өнөкөт обструктивдүү оорусу бар пациенттерде спирометриялык көрсөткүчтөр. Кыргызстандын саламаттык сактоо 2023, № 4, б. 10-16. https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
Authors Asanbaeva A.A., Brimkulov N.N.
Link doi.org https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
Pages 10-16
Keywords high-altitude, Chronic obstructive disease, Spirometry, Vital capacity, Peak expiratory flow
Russian
Об авторах

Асанбаева Анара Абдимиталиповна, аспирант кафедры семейной медицины последипломного образования Кыргызской государственной медицинской академии им. И. К. Ахунбаева, Бишкек, Кыргызская Республика

Бримкулов Нурлан Нургазиевич, доктор медицинских наук, профессор, заведующий кафедрой семейной медицины последипломного образования Кыргызской государственной медицинской ака демии им. И. К. Ахунбаева, Бишкек, Кыргызская Республика
Полный текст

PDF (RUS)
Список литературы
  1. Celli B.R., Singh D., Vogelmeier C., Agusti A. New Perspectives on Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022, no. 17, pp. 2127-2136.
  2. Avdeev S., Aisanov Z., Arkhipov V., et al. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. Int J COPD. 2019, no.14, pp. 1267-80.
  3. АжимаматоваР.М., КалматовР.К. Распространенность и социально-экономический ущерб от болезней органов дыхания в мире, в том числе в Кыргызской Республике // Вестник Ошского государственного университета. -2020. -№ 1-5.- C.18-24. [Azhimamatova R.M., Kalmatov R.K. Prevalence and social-economic damage of respiratory diseases in the worldwide including Kyrgyz Republic. // Bulletin of Osh State University. 2020;1(5) 18-24 (In Russ.)].
  4. Драпкина О.М., Концевая А.В., Муканеева Д.К., Смирнова М.И., Анциферова А.А., Лукьянов М.М., Мырзаматова А.О., Моховиков Г.И., Худяков М.Б., Авдеев С.Н. Прогноз социально-экономического бремени хронической обструктивной болезни легких в Российской Федерации в 2022 году. // Пульмонология. 2022;32(4): С. 507-516. [Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M., Myrzamatova A.O., Mokhovikov G.I., Khudyakov M.B., Avdeev S.N. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022.  2022;32(4):507-516. (In Russ.)].
  5. Tollånes M.C., Sjaastad G.E., Aarli B.B., Sandberg S. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Pract. 2020. Vol.21, no.1, P. 235.
  6. Soumagne T., Guillien A., Roux P., et al. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice. Respiratory Medicine and Research. 2020, no,77. pp. 31-36.
  7. Graham B.L, Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper Bg., et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019, vol.200, no.8, pp.e70-e88.
  8. Vinnikov D,V., Raushanova A, Kyzayeva A, Romanova Z, Tulekov Z.D., et al. Lifetime Occupational history, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int J Chron Obstruct Pulmon Dis. 2019, vol.14, pp.3025-3034.
  9. Athlin Å., Lisspers K., Hasselgren M., et al. Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. Npj Prim. Care Respir. Med. 2023, no 33, P. 23.
  10. Lange A.V., Mehta A.B., BekelmanB. How Important is Spirometry for Identifying Patients with COPD Appropriate for Palliative Care? Journal of Pain and Symptom Management. 2023, vol.65. no.3, pp. e181-e187.

                                                                                               

Для цитирования

Асанбаева А.А., Бримкулов Н.Н. Показатели спирометрии у больных ХОБЛ в условиях низко и высокогорья. Здравоохранение Кыргызстана 2023, № 4, с.10-16. https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
English
About authors

Asanbaeva Anara Abdimitalipovna, graduate student of the Department of Family Medicine of Postgraduate Education of the Kyrgyz State Medical Academy named after. I. K. Akhunbaeva, Bishkek, Kyrgyz Republic

Brimkulov Nurlan Nurgazievich, Doctor of Medical Sciences, Professor, Head of the Department of Family Medicine of Postgraduate Education of the Kyrgyz State Medical Academy named after. I. K. Akhun baeva, Bishkek, Kyrgyz Republic
References
  1. Celli B.R., Singh D., Vogelmeier C., Agusti A. New Perspectives on Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022, no. 17, pp. 2127-2136.
  2. Avdeev S., Aisanov Z., Arkhipov V., et al. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. Int J COPD. 2019, no.14, pp. 1267-80.
  3. АжимаматоваР.М., КалматовР.К. Распространенность и социально-экономический ущерб от болезней органов дыхания в мире, в том числе в Кыргызской Республике // Вестник Ошского государственного университета. -2020. -№ 1-5.- C.18-24. [Azhimamatova R.M., Kalmatov R.K. Prevalence and social-economic damage of respiratory diseases in the worldwide including Kyrgyz Republic. // Bulletin of Osh State University. 2020;1(5) 18-24 (In Russ.)].
  4. Драпкина О.М., Концевая А.В., Муканеева Д.К., Смирнова М.И., Анциферова А.А., Лукьянов М.М., Мырзаматова А.О., Моховиков Г.И., Худяков М.Б., Авдеев С.Н. Прогноз социально-экономического бремени хронической обструктивной болезни легких в Российской Федерации в 2022 году. // Пульмонология. 2022;32(4): С. 507-516. [Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M., Myrzamatova A.O., Mokhovikov G.I., Khudyakov M.B., Avdeev S.N. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022.  2022;32(4):507-516. (In Russ.)].
  5. Tollånes M.C., Sjaastad G.E., Aarli B.B., Sandberg S. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Pract. 2020. Vol.21, no.1, P. 235.
  6. Soumagne T., Guillien A., Roux P., et al. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice. Respiratory Medicine and Research. 2020, no,77. pp. 31-36.
  7. Graham B.L, Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper Bg., et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019, vol.200, no.8, pp.e70-e88.
  8. Vinnikov D,V., Raushanova A, Kyzayeva A, Romanova Z, Tulekov Z.D., et al. Lifetime Occupational history, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int J Chron Obstruct Pulmon Dis. 2019, vol.14, pp.3025-3034.
  9. Athlin Å., Lisspers K., Hasselgren M., et al. Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. Npj Prim. Care Respir. Med. 2023, no 33, P. 23.
  10. Lange A.V., Mehta A.B., BekelmanB. How Important is Spirometry for Identifying Patients with COPD Appropriate for Palliative Care? Journal of Pain and Symptom Management. 2023, vol.65. no.3, pp. e181-e187.

                                                                                               
For citation

Asanbaeva A.A., Brimkulov N.N. Spirometry indicators in patients with chronic obstructive pulmonary disease in low and high altitude conditions Health care of Kyrgyzstan 2023,  No.4, pp.10-16. https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
Kyrgyz
Авторлор жөнүндө

Асанбаева Анара Абдимиталиповна, И.К. Ахунбаев атындагы Кыргыз мамлекеттик медициналык академиясынын дипломдон кийинки билим берүү үй-бүлөлүк медицина кафедрасынын аспиранты, Бишкек, Кыргыз Республикасы

Бримкулов Нурлан Нургазиевич, медицина илимдеринин доктору, профессор, И.К. Ахунбаев атындагы Кыргыз мамлекеттик медициналык академиясынын дипломдон кийинки билим берүү үй-бүлөлүк медицина кафедрасынын башчысы, Бишкек, Кыргыз Республикасы
Шилтемелер
  1. Celli B.R., Singh D., Vogelmeier C., Agusti A. New Perspectives on Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022, no. 17, pp. 2127-2136.
  2. Avdeev S., Aisanov Z., Arkhipov V., et al. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. Int J COPD. 2019, no.14, pp. 1267-80.
  3. АжимаматоваР.М., КалматовР.К. Распространенность и социально-экономический ущерб от болезней органов дыхания в мире, в том числе в Кыргызской Республике // Вестник Ошского государственного университета. -2020. -№ 1-5.- C.18-24. [Azhimamatova R.M., Kalmatov R.K. Prevalence and social-economic damage of respiratory diseases in the worldwide including Kyrgyz Republic. // Bulletin of Osh State University. 2020;1(5) 18-24 (In Russ.)].
  4. Драпкина О.М., Концевая А.В., Муканеева Д.К., Смирнова М.И., Анциферова А.А., Лукьянов М.М., Мырзаматова А.О., Моховиков Г.И., Худяков М.Б., Авдеев С.Н. Прогноз социально-экономического бремени хронической обструктивной болезни легких в Российской Федерации в 2022 году. // Пульмонология. 2022;32(4): С. 507-516. [Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K., Smirnova M.I., Antsiferova A.A., Lukyanov M.M., Myrzamatova A.O., Mokhovikov G.I., Khudyakov M.B., Avdeev S.N. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022.  2022;32(4):507-516. (In Russ.)].
  5. Tollånes M.C., Sjaastad G.E., Aarli B.B., Sandberg S. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Pract. 2020. Vol.21, no.1, P. 235.
  6. Soumagne T., Guillien A., Roux P., et al. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice. Respiratory Medicine and Research. 2020, no,77. pp. 31-36.
  7. Graham B.L, Steenbruggen I., Miller M.R., Barjaktarevic I.Z., Cooper Bg., et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019, vol.200, no.8, pp.e70-e88.
  8. Vinnikov D,V., Raushanova A, Kyzayeva A, Romanova Z, Tulekov Z.D., et al. Lifetime Occupational history, Respiratory Symptoms and Chronic Obstructive Pulmonary Disease: Results from a Population-Based Study. Int J Chron Obstruct Pulmon Dis. 2019, vol.14, pp.3025-3034.
  9. Athlin Å., Lisspers K., Hasselgren M., et al. Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. Npj Prim. Care Respir. Med. 2023, no 33, P. 23.
  10. Lange A.V., Mehta A.B., BekelmanB. How Important is Spirometry for Identifying Patients with COPD Appropriate for Palliative Care? Journal of Pain and Symptom Management. 2023, vol.65. no.3, pp. e181-e187.

                                                                                               
Цитата үчүн

Асанбаева А.А., Бримкулов Н.Н. Төмөнкү жана бийик тоолуу шарттарда өпкөнүн өнөкөт обструктивдүү оорусу бар пациенттерде спирометриялык көрсөткүчтөр. Кыргызстандын саламаттык сактоо 2023, № 4, б. 10-16. https://dx.doi.org/10.51350/zdravkg2023.4.12.1.10.16
Views: 1424
Copyright MAXXmarketing GmbH
JoomShopping Download & Support